Compare DexCom, Inc. (DXCM) vs National Energy Services Reunited Corp Ordinary Shares (NESR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs National Energy Services Reunited Corp Ordinary Shares — how do they compare? DexCom, Inc. trades at $86 (market cap $31.51B), while National Energy Services Reunited Corp Ordinary Shares trades at $18.94 (market cap $1.97B). The key difference: DexCom, Inc. is far larger — about 16× National Energy Services Reunited Corp Ordinary Shares's market cap, and DexCom, Inc. is trading nearer its 52-week high, National Energy Services Reunited Corp Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and National Energy Services Reunited Corp Ordinary Shares for 0 Days on average.
| DXCM | NESR | |
|---|---|---|
Market Cap | $31.51B | $1.97B |
Volume | 3,480,291 | 4,629,858 |
Sector | Health | Energy |
52-Week High | $92.34 | $36.31 |
52-Week Low | $54.84 | $10.41 |
Typical Hold Time | 62 Days | 0 Days |
Enterprise Value | $30.96B | $2.10B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $85.06, down 1.0% on the day, with a bullish technical signal and strong fundamental momentum. The stock is supported by consistent earnings beats, robust revenue growth from $4.0B in 2024 to $4.7B in 2025, and expanding net profit margins to 17.93%. Recent news highlights growth opportunities in Type 2 diabetes care and leadership appointments, reinforcing positive sentiment. Key resistance sits at $87, with immediate support at $85.
The outlook remains favorable given analyst consensus of a $96.14 price target and 80.77% buy ratings, though risks include competitive pressures and reimbursement challenges. Upside is driven by CGM adoption growth, while execution on guidance and market expansion are critical for sustained performance.
NESR trades at $21.03, up 0.62% today, with neutral technical signals and strong fundamental momentum. The company has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $0.44 exceeding expectations by 25%. Revenue growth remains robust, driven by Middle East operations including the Jafurah gas field expansion. Analyst sentiment is overwhelmingly positive with 83% buy ratings and a consensus price target of $41.80, representing nearly 100% upside potential.
The outlook remains favorable with projected revenue growth to $1.6B in 2026 and net profit doubling to $93M. Key risks include execution pressure from premium valuation and regional geopolitical uncertainties. The recent lithium extraction deal with Saudi Aramco provides additional growth optionality, though capital demands remain elevated. Current levels offer attractive entry for growth-oriented investors despite technical neutrality.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About National Energy Services Reunited Corp Ordinary Shares
National Energy Services Reunited Corp (NESR) is a Houston-based oilfield services company that provides drilling, evaluation, and production services, including hydraulic fracturing, cementing, coiled tubing, and directional drilling, to oil and gas operators. It focuses primarily on markets across the Middle East, North Africa, and Asia Pacific.
Read more on NESR →
